← Back to Clinical Trials
Recruiting NCT06646601

NCT06646601 A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06646601
Status Recruiting
Phase
Sponsor Assistance Publique Hopitaux De Marseille
Condition Vascular Disease
Study Type INTERVENTIONAL
Enrollment 157 participants
Start Date 2024-04-09
Primary Completion 2026-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Intervention of prevention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 157 participants in total. It began in 2024-04-09 with a primary completion date of 2026-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A preventive, multidisciplinary primary care intervention organized around a therapeutic garden: Acceptability to patients suffering from cardio-neurovascular pathology and to those involved in the action.

Eligibility Criteria

Inclusion Criteria: * age \> 18 years old; * living in the vicinity (+-20 km) of Gap, Laragne-Montéglin, Veynes and Clermont-Ferrand; * having been invited to take part in the intervention by the caregivers of the medical structures * suffering from an ALD based on CNAM medical criteria (stroke, AOMI, rhythm disorders, valvular heart disease, congenital heart disease, stage I and II heart failure), severe hypertension, chronic coronary disease) Exclusion Criteria: * heart failure based on CNAM medical criteria (ALD n°5) stage III and IV according to NYHA classification ; * with a contraindication to physical activity ; * living in an institution; * unable to walk more than 100 m independently; * Alzheimer's disease or other dementias based on CNAM medical criteria ; * with an unlabelled cognitive impairment limiting comprehension.

Contact & Investigator

Central Contact

Julie Gardette, Dr

✉ promotion.interne@ap-hm.fr

📞 +33491381245

Frequently Asked Questions

Who can join the NCT06646601 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Vascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06646601 currently recruiting?

Yes, NCT06646601 is actively recruiting participants. Contact the research team at promotion.interne@ap-hm.fr for enrollment information.

Where is the NCT06646601 trial being conducted?

This trial is being conducted at Gap, France.

Who is sponsoring the NCT06646601 clinical trial?

NCT06646601 is sponsored by Assistance Publique Hopitaux De Marseille. The trial plans to enroll 157 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology